PT Indofarma Tbk

Rp 126.00As of Sun 8 Nov 2026, 12:00 UTC
IDX:INAFHealthcare
Country Indonesia
PE (Fwd) •••
TSR 10Y CAGR (25.96%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.28
PE TTM 18.12
TSR TTM —
Mkt cap Rp 390.5B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
Rp 147
16.75%
(46.81%)
Hold 4|3|11|12|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareRp
2.57
2.49
2.61
2.88
1.64%
(0.56%)
(4.03%)
7.00%
RevenueRp B
44.03
43.90
44.09
43.74
(4.92%)
(4.79%)
(2.82%)
(3.42%)
Peers (US$21.57M)
Cap (US$)
PE
86.37M
6.555x
12.25M
4.268x
Capital
TTM
5Y
10Y
Leveragex
1.830
0.035
0.032
EBIT/Intx
1.498
0.361
0.308
Own earn%
(41.89)
(33.14)
(35.17)
Sh yield%
28.70
29.34
30.44
Owners
Insiders/Inst%
4.79
54.53
Short interest%
3.87
SBC / revenue%
0.27
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
13–16
$1 testx
0.1
Incr. ROIC%
61